
Chronic myelogenous leukaemia (CML) is an uncommon bone marrow malignancy. Bone marrow is the spongy substance found inside bones that produces blood cells. CML increases the quantity of white blood cells in the bloodstream.
The term chronic in chronic myelogenous leukaemia refers to cancer that progresses more slowly than severe kinds of leukaemia. The term myelogenous relates to the cells affected by this malignancy.
Chronic myelogenous leukaemia is also known as chronic myeloid or chronic granulocytic leukaemia. It mainly affects older adults and is infrequently seen in children, but can happen at any age.
Advances in treatment have improved the prognosis for persons with chronic myelogenous leukaemia.
Chronic Myeloid Leukemia (CML) must be treated as soon as possible to improve patient outcomes and manage the disease efficiently.
Early treatment can keep the disease from developing to the more aggressive blastic phase, which is more challenging to treat. Early therapy increases long-term survival rates and lowers the chance of complications, relapses, or progression to acute leukaemia, which has inferior outcomes.
Furthermore, timely therapy aids in the control of symptoms such as fatigue, weight loss, and pain, allowing patients to maintain a higher quality of life. Therefore, early and consistent therapy of CML is essential for better disease control, increased survival, and improved overall health.
Chronic myelogenous leukaemia is generally asymptomatic. A blood test may identify it. Symptoms may include:
Causes
Chronic myelogenous leukaemia occurs when something changes the bone marrow cells.
Risk Factors
The following factors enhance the risk of chronic myelogenous leukaemia:
Complications
Individuals with CML may develop:
Some prevention tips for Chronic Myeloid Leukemia (CML):
These tips support overall health but cannot specifically prevent CML.
Targeted therapy: Targeted therapy focuses on specific molecules in cancer cells, such as the tyrosine kinase protein in chronic myelogenous leukemia.
Cost Start From USD 8000 - USD 12000Explore Options
Bone marrow transplant: A bone marrow transplant heals chronic myelogenous leukemia, although it is only recommended for patients who have not received previous treatments due to the dangers and problems involved. High-dose chemotherapy destroys blood-forming cells, while donor blood stem cells replace damaged ones.
Cost Start From USD 25000 - USD 35000Explore Options
Chemotherapy: Chemotherapy employs potent medications to attack cancer cells. Medicines for chemotherapy are occasionally coupled with targeted therapy to treat aggressive chronic myelogenous leukemia.
Cost Start From USD 600 - USD 700Explore Options
The following tests and procedures diagnose Chronic myeloid leukaemia (CML):
MediGence can assist and guide you in selecting the best physician and medical facility for your care.
Depending on the circumstances, your doctor may prescribe medication to assist you in managing your symptoms and support your treatment plan.
Treatment regimens are adapted to the patient's specific cancer stage and location.









Gurugram, India
Sanar International Hospital is a multispeciality hospital based on Golf Course Road in Gurugram, a part of Delhi NCR. It was founded in 2018 and houses one of the most comprehensive and advanced surgical care specialties. This 150-bedded facility is committed to providing the best patient experiences and healthcare services is the core of the hospital’s mission. Staffed by a group of visionary and competent medical professionals who are well-versed in their fields and eminent for their empathy and understanding, Sanar International Hospital provides optimal care to its patients, making it a popular
Specialties in the Hospital such as Heart, Bone, and Joint neurosciences, Cancer, Kidney and Liver Transplant, and other successful procedures along with experienced medical professionals have made a mark for themselves among domestic patients and international patients who come to India to have the finest healthcare services. It follows strict international practices and believes that the centricity of the patient is essential for providing high-quality care through world-class infrastructure and state-of-the-art facilities. The technologies offered by the Hospital include Digital X-rays, MRI, CT, Ultrasound, transfusion medicine, pharmacy, laboratory services, 24 hrs emergency and ambulance services.
It offers more than 20 plus specialties such as General Medicine, Anesthesiology, Cardiac Sciences, Ophthalmology, Gastroenterology, Hematology, Orthopedics, General Surgery & Surgical, Cardiothoracic Surgery, Hepato Biliary Surgery, Pediatrics, Liver Transplantation, and Critical Care Medicine. The Hospital has a highly skilled medical staff of neuro-anesthetists, neurologists, specialized neurocritical care experts, neurosurgeons neuropsychologists, and neuropsychiatrists. There are specific centers for the treatment of epilepsy, stroke, brain tumors, movement disorders, spinal problems, and headaches.

Ahmedabad, India
Apollo Hospital International Limited located in Ahmedabad, India is accredited by JCI, NABH. Also listed below are some of the most prominent infrastructural details:

Gurgaon, India
Manipal Hospital, Gurgaon, which used to be Columbia Asia Hospital, is a 100-bed, multispecialty facility that was established in 2008. It is recognized by NABH, and offers complete care in six specialties: neurology, cardiology, oncology, gynecology, orthopedics, and psychiatry. By bringing together modern infrastructure, sophisticated technology, and a team of qualified medical and nursing staff as a part of its value system, the hospital emphasizes ethics and high-quality, affordable healthcare. The hospital maintains an integrated and collaborative framework, and is able to provide 24/7 emergency services and critical care, to achieve the best possible outcomes, with patient satisfaction and treatment as a whole being a fundamental feature of the service.
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Here are some of the reasons for choosing India:
The success rate is excellent, particularly if the condition is detected early. TKIs work well for 80-90% of patients, resulting in long-term remission and excellent disease management.
Although recurrence is uncommon, it can occur, particularly if the disease is not properly controlled or the patient grows resistant to treatment. Relapsed CML can be managed by regular monitoring and treatment changes.
Side effects differ depending on the specific tyrosine kinase inhibitors (TKIs), but may include:
Yes, India has several specialist cancer centers that provide cutting-edge CML therapy, including access to clinical trials and novel treatments.
Yes, it can. CML patients may be more likely to develop other types of cancer (second malignancies). A recent study found that approximately 30% of persons with chronic myeloid leukemia got second malignancies, including:
CML can occur anywhere in India, although there is no compelling evidence that it is more prevalent in any particular region. However, healthcare accessibility and awareness may differ by geography, with better diagnosis and treatment available in major cities.
Stem cell transplants are explored when the illness does not respond to TKIs or there is a relapse. The surgery is accessible at many major hospitals across India, although it is typically chosen as a last resort due to its complexity and cost